Brain+ adds new clinical and development competencies to accelerate and support market access of its digital dementia product portfolio
Copenhagen, Denmark, October 27, 2022 – Brain+ A/S (Nasdaq First North: BRAINP) · Rising star clinical dementia researcher to join the company in a new position as Clinical Director · Recently, development was also strengthened with a Quality Manager and a Clinical Research Associate · The new hires represent a significant competence upgrade and expansion of the clinical team for a more efficient product development and commercializationBrain+ (BRAINP), a pioneer in the development of digital therapeutics for Alzheimer’s disease and dementia, has hired Nahid Zokaei to a new